National Association of Testing Authorities, Australia
Scope of Accreditation
Hudson Institute of Medical Research
Site
Hudson Institute Cell Therapies
Accreditation No.
21322
Site No.
25678
Date of Accreditation
04 Oct 2024
Contact
Dr Mirja Krause P: +61 (03) 85722802
Availability
Services conditionally available to external clients
Supervision
HPS (Haemopoietic processing, storage)
Scope of Accreditation
Hudson Institute Cell Therapies
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Service | Product | Determinant |
---|---|---|
Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProducts received from AN 21171 SN 25469 | Haemopoietic progenitor cells | Processing; Storage (includes freezing/thawing) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
21322
Site No.
25678
Print date
23 Nov 2024
END OF SCOPE